Form 4: Arteris Inc. Director Saiyed Atiq Raza Executes Stock Sale Under 10b5-1 Plan

Director Saiyed Atiq Raza sold 41,439 shares of Arteris, Inc. common stock at an average price of $10.3655, as part of a pre-arranged 10b5-1 trading plan.

Summary

• On December 26, 2024, Saiyed Atiq Raza, a director of Arteris, Inc., sold 41,439 shares of common stock.
• The sale was executed under a pre-arranged 10b5-1 trading plan adopted on June 6, 2024.
• The shares were sold at prices ranging from $10.00 to $10.67, with a weighted average sale price of $10.3655.
• Following the transaction, Raza directly owns 19,287 shares and indirectly owns 690,121 shares through the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust.
• The reporting person serves as trustee for the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to an insider stock sale. It doesn't inherently convey positive or negative sentiment, as it's a factual report of a transaction.

Industry Context

Sales by company insiders are a common occurrence and are often pre-planned to avoid accusations of trading on inside information. The use of a 10b5-1 trading plan allows insiders to sell shares at predetermined times and prices.

Stakeholder Impact

• The stock sale by a director could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates